Michael Kraus

Title: Michael Kraus: Innovator in Coagulation Factor Production

Introduction

Michael Kraus is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of biochemistry, particularly in the production of coagulation factors. With a total of three patents to his name, Kraus has demonstrated his expertise and commitment to advancing medical science.

Latest Patents

Kraus's latest patents include innovative methods for producing thrombin and enriching coagulation factors. One of his patents details a method of producing thrombin from Factor II using calcium ions. This method outlines the steps necessary to efficiently convert prothrombin into thrombin. Another patent focuses on the enrichment of coagulation Factors II, VII, IX, and X. This method involves adsorbing these factors onto a polymeric matrix that carries an α-hydroxylamine group, allowing for effective elution and concentration of the factors.

Career Highlights

Throughout his career, Michael Kraus has worked at Biotest Pharma GmbH, where he has been instrumental in developing new techniques for blood factor production. His work has contributed to advancements in therapeutic applications for patients with coagulation disorders. Kraus's innovative approaches have positioned him as a key figure in the biopharmaceutical industry.

Collaborations

Kraus has collaborated with esteemed colleagues such as Wolfgang Moller and Bertram Eichentopf. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the field.

Conclusion

Michael Kraus is a distinguished inventor whose contributions to the production of coagulation factors have made a significant impact in the medical field. His innovative patents and collaborative efforts continue to advance the science of biochemistry and improve patient outcomes.